Genistein was reported to mediate proliferative inhibition and apoptotic induction in NSCLC through suppressive activities towards the PI3K/AKT/HIF1A/VEGF and NF-κB/COX2 signaling pathways, which enhanced the production of ROS [162]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.